|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steeg PS: Targeting metastasis. Nat Rev
Cancer. 16:201–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heestand GM and Kurzrock R: Molecular
landscape of pancreatic cancer: Implications for current clinical
trials. Oncotarget. 6:4553–4561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Melisi D, Calvetti L, Frizziero M and
Tortora G: Pancreatic cancer: Systemic combination therapies for a
heterogeneous disease. Curr Pharm Des. 20:6660–6669. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu H, Yang L and Chen LL: The diversity of
long noncoding RNAs and Their Generation. Trends Genet. 33:540–552.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren
Y, Wu Y, Mei M, Zhang L and Wang X: Long non coding RNA MALAT1
promotes tumor growth and metastasis by inducing
epithelial-mesenchymal transition in oral squamous cell carcinoma.
Sci Rep. 5:159722015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang J, Zhong G, Wu J, Chen H and Jia Y:
Long noncoding RNA AFAP1-AS1 facilitates tumor growth through
enhancer of zeste homolog 2 in colorectal cancer. Am J Cancer Res.
8:892–902. 2018.PubMed/NCBI
|
|
10
|
Luo H, Yang L, Liu C, Wang X, Dong Q, Liu
L and Wei Q: TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to
the progression of bladder cancer. Int J Biochem Cell Biol.
122:1057022020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin X, Liu X, Zhang Z and Guan Y: lncRNA
CCAT1 Acts as a MicroRNA-218 sponge to increase gefitinib
resistance in NSCLC by targeting HOXA1. Mol Ther Nucleic Acids.
19:1266–1275. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Cui J, Niu W, Huang J, Feng T, Sun B
and Yao H: Long non-coding PCED1B-AS1 regulates macrophage
apoptosis and autophagy by sponging miR-155 in active tuberculosis.
Biochem Biophys Res Commun. 509:803–809. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Y, Wang Z, Zhang W and Zhang L:
MicroRNAs play an essential role in autophagy regulation in various
disease phenotypes. Biofactors. 45:844–856. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang J, Yu D, Liu X, Changyong E and Yu S:
LncRNA PCED1B-AS1 activates the proliferation and restricts the
apoptosis of glioma through cooperating with miR-194-5p/PCED1B
axis. J Cell Biochem. 121:1823–1833. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan CL, Jiang XM, Yi Y, E JF, Zhang ND,
Luo X, Zou N, Wei W and Liu YY: Identification of differentially
expressed lncRNAs and mRNAs in luminal-B breast cancer by
RNA-sequencing. BMC Cancer. 19:11712019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye Y, Li SL and Wang SY: Construction and
analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal
the key genes associated with prostate cancer. PLoS One.
13:e01980552018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duguang L, Jin H, Xiaowei Q, Peng X,
Xiaodong W, Zhennan L, Jianjun Q and Jie Y: The involvement of
lncRNAs in the development and progression of pancreatic cancer.
Cancer Biol Ther. 18:927–936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao L, Kong H, Sun H, Chen Z, Chen B and
Zhou M: LncRNA-PVT1 promotes pancreatic cancer cells proliferation
and migration through acting as a molecular sponge to regulate
miR-448. J Cell Physiol. 233:4044–4055. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen J, Hong L, Yu D, Cao T, Zhou Z and He
S: LncRNA XIST promotes pancreatic cancer migration, invasion and
EMT by sponging miR-429 to modulate ZEB1 expression. Int J Biochem
Cell Biol. 113:17–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng H, Wei B and Zhang Y: Long non-coding
RNA HULC promotes proliferation, migration and invasion of
pancreatic cancer cells by down-regulating microRNA-15a. Int J Biol
Macromol. 126:891–898. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Puppo M, Battaglia F, Ottaviano C, Delfino
S, Ribatti D, Varesio L and Bosco MC: Topotecan inhibits vascular
endothelial growth factor production and angiogenic activity
induced by hypoxia in human neuroblastoma by targeting
hypoxia-inducible factor-1alpha and −2alpha. Mol Cancer Ther.
7:1974–1984. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren W, Mi D, Yang K, Cao N, Tian J, Li Z
and Ma B: The expression of hypoxia-inducible factor-1α and its
clinical significance in lung cancer: A systematic review and
meta-analysis. Swiss Med Wkly. 143:w138552013.PubMed/NCBI
|
|
23
|
Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS
and Wu KJ: Prognostic significance of hypoxia-inducible
factor-1alpha, TWIST1 and Snail expression in resectable non-small
cell lung cancer. Thorax. 64:1082–1089. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu YL, Hu LN, Zheng CD, Sun RC, Zhang SX,
Yan Q and Li YX: Expression of hypoxia-inducible factor 1α in
gastric cancer and its clinical signficance. Zhonghua Yi Xue Za
Zhi. 96:1418–1423. 2016.(In Chinese). PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paraskevopoulou MD, Vlachos IS, Karagkouni
D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P,
Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2:
Indexing microRNA targets on non-coding transcripts. Nucleic Acids
Res. 44:D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abdollahzadeh R, Daraei A, Mansoori Y,
Sepahvand M, Amoli MM and Tavakkoly-Bazzaz J: Competing endogenous
RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A
new look at hallmarks of breast cancer. J Cell Physiol.
234:10080–10100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wan Y, Yao Z, Chen W and Li D: The lncRNA
NORAD/miR-520a-3p facilitates malignancy in non-small cell lung
cancer via PI3k/Akt/mTOR signaling pathway. Onco Targets Ther.
13:1533–1544. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang J, Wu W, Wu M and Ding J: Long
noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and
EMT process through regulating miR-3196/OTX1 axis in breast cancer.
In VitroCell Dev Biol Anim. 55:522–532. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Halvorsen AR, Sandhu V, Sprauten M, Flote
VG, Kure EH, Brustugun OT and Helland Å: Circulating microRNAs
associated with prolonged overall survival in lung cancer patients
treated with nivolumab. Acta Oncol. 57:1225–1231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Huang Y, Liu H, Su D, Luo F and
Zhou F: Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to
regulate ovarian cancer in vitro and in vivo through
HIF-1a/VEGF/P38 pathway. Biochem Biophys Res Commun. 514:44–50.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu Y, Li Y, Wang Z, Xie S, Wang Q, Lei X,
Ruan Y and Li J: Downregulation of RGMA by HIF-1A/miR-210-3p axis
promotes cell proliferation in oral squamous cell carcinoma. Biomed
Pharmacother. 112:1086082019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sohn SH, Kim B, Sul HJ, Choi BY, Kim HS
and Zang DY: Foretinib inhibits cancer stemness and gastric cancer
cell proliferation by decreasing CD44 and c-MET signaling. Onco
Targets Ther. 13:1027–1035. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma D, Fan SB, Hua N, Li GH, Chang Q and
Liu X: Hypermethylation of single CpG dinucleotides at the promoter
of CXCL13 gene promoting cell migration in cervical cancer. Curr
Cancer Drug Targets. 20:355–363. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang QC, Zeng BF, Shi ZM, Dong Y, Jiang
ZM, Huang J, Lv YM, Yang CX and Liu YW: Inhibition of
hypoxia-induced angiogenesis by trichostatin A via suppression of
HIF-1a activity in human osteosarcoma. J Exp Clin Cancer Res.
25:593–599. 2006.PubMed/NCBI
|
|
38
|
Li W, Zong S, Shi Q, Li H, Xu J and Hou F:
Hypoxia-induced vasculogenic mimicry formation in human colorectal
cancer cells: Involvement of HIF-1a, claudin-4, and E-cadherin and
Vimentin. Sci Rep. 6:375342016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shen Y, Chen G, Zhuang L, Xu L, Lin J and
Liu L: ARHGAP4 mediates the Warburg effect in pancreatic cancer
through the mTOR and HIF-1α signaling pathways. Onco Targets Ther.
12:5003–5012. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shukla SK, Purohit V, Mehla K, Gunda V,
Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, et
al: MUC1 and HIF-1alpha signaling crosstalk induces anabolic
glucose metabolism to impart gemcitabine resistance to pancreatic
cancer. Cancer Cell. 32:71–87.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Colbert LE, Fisher SB, Balci S, Saka B,
Chen Z, Kim S, El-Rayes BF, Adsay NV, Maithel SK, Landry JC and
Curran WJ Jr: High nuclear hypoxia-inducible factor 1 alpha
expression is a predictor of distant recurrence in patients with
resected pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys.
91:631–639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wilkes JG, O'Leary BR, Du J, Klinger AR,
Sibenaller ZA, Doskey CM, Gibson-Corley KN, Alexander MS, Tsai S,
Buettner GR and Cullen JJ: Pharmacologic ascorbate (P-AscH-)
suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic
adenocarcinoma. Clin Exp Metastasis. 35:37–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang H, Jia R, Zhao T, Li X, Lang M, Lan
C, Wang H, Li Z, Zhou B, Wu L, et al: HIF-1α mediates tumor-nerve
interactions through the up-regulation of GM-CSF in pancreatic
ductal adenocarcinoma. Cancer Lett. 453:10–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang H, Chen J, Liu F, Gao C, Wang X,
Zhao T, Liu J, Gao S, Zhao X, Ren H and Hao J: CypA, a gene
downstream of HIF-1α, promotes the development of PDAC. PLoS One.
9:e928242014. View Article : Google Scholar : PubMed/NCBI
|
